The increasing number of novel tobacco products has prompted the agency to review its processes, procedures and leadership structure - Treatment Magazine
Work is poised to get underway on a somewhat rare internal review by the U.S. Food and Drug Administration (FDA) that could impact how the agency processes new tobacco products and enforces the sale of them by retailers.